What Your CGM Wear-Time Means for Blood Sugar Readings
A new study shows that Time-in-Range data from continuous glucose monitors remains useful even when you wear your sensor less often—though consistency matters for accuracy.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Time-in-Range (TIR) correlates with HbA1c across different CGM wear schedules, but the link is stronger when you wear your sensor 70% or more of the time
- Even with less consistent wear, CGM data can still provide meaningful insight into your blood sugar patterns
- The takeaway for real life: more sensor wear gives you more reliable information, but partial data is better than no data
Why This Matters
If you wear a continuous glucose monitor, you've probably heard that Time-in-Range (TIR)—the percentage of time your blood sugar stays in your target range—is an important number to track. Research has shown that a TIR above 70% tends to predict better long-term blood sugar control, measured by HbA1c tests.
But what happens when life gets messy? When you miss sensor changes, forget to insert a new one, or simply take breaks from wearing your CGM? A new study in the Journal of Diabetes and Its Complications examined whether TIR data still tells a meaningful story when you're not wearing your sensor consistently.
The Study: What Researchers Found
Scientists followed 60 young people with Type 1 diabetes and divided them into two groups: those who wore their CGM at least 70% of the time, and those who wore it less than 70% of the time. They then looked at how closely each person's TIR matched their HbA1c results.
The results showed that TIR and HbA1c were strongly linked in the consistent-wear group (those with ≥70% wear-time). The relationship was noticeably weaker in the less-consistent group, but still statistically significant—meaning it wasn't due to chance.
What Does This Mean for You?
The headline: wearing your CGM more consistently gives you a clearer picture of your blood sugar patterns and a more reliable TIR number. This makes sense—more data points mean better accuracy.
But here's the encouraging part: even if your wear-time isn't perfect, the TIR data you do collect still carries value. Your CGM readings aren't useless just because they don't cover every single hour of the day.
This matters in the real world, where life happens. Work stress, skin sensitivity, sensor failures, or simply needing a break can all interrupt consistent CGM use. Knowing that partial data still reflects your overall glycemic control can help you feel less discouraged about imperfect adherence.
The Practical Takeaway
Aim for at least 70% CGM wear-time when possible—it gives your healthcare team and you the most reliable picture of how your diabetes management is working.
If you can't wear your sensor all the time, don't panic. The data you do collect still tells part of your blood sugar story and can guide conversations with your care team about next steps.
Evidence label
Source: Journal of diabetes and its complications. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature